|1y Target Est:||N/A|
|Avg Vol (3m):|
|Div & Yield:||N/A|
Buckner Daily - 3 days ago
Easton Pharmaceuticals Inc. (OTCPK:EAPH) presently has an EV or Enterprise Value of 12559. The EV helps show how the market assigns value to a company as a whole. EV is a modification of market cap,...
GlobeNewswire (press release) - 2 months ago
TORONTO, ON, June 20, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) is pleased to announce a new director and officer to its board with the appointment of Mr. Vince Demasi of...
Markets Insider - 11 months ago
Global Payout, Inc. (OTC: GOHE), mCig, Inc. (OTC: MCIG), 22nd Century Group Inc. (NYSE: XXII), Easton Pharmaceuticals, Inc. (OTC: EAPH), AXIM Biotechnologies, Inc. (OTC: AXIM). One major obstacle of...
Markets Insider - 12 months ago
Easton Pharmaceuticals, Inc. (OTC: EAPH) s is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. According to the company's...
News via Google. See more news matching 'stock EAPH business news'